Search filters

List of works by Joseph Gligorov

1st International consensus guidelines for advanced breast cancer (ABC 1).

scientific article published on 16 March 2012

A Serologic Marker of Paraneoplastic Limbic and Brain-Stem Encephalitis in Patients with Testicular Cancer

scientific article published on 01 November 1999

A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy

scientific article

A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study

scientific article published on 03 June 2014

Acute kidney failure with renal carcinomatous lymphangitis secondary to advanced colon cancer.

scientific article published in August 2013

Adjuvant breast cancer treatment with hormono-radiotherapy

scientific article published in March 2009

Adjuvant treatments for triple-negative breast cancers ⬇️

scientific article published on August 1, 2012

Bevacizumab et actes invasifs : recommandations pratiques

scientific article published on 01 February 2009

Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, rando

scientific article published on 28 September 2014

Breast Cancer Management during the COVID 19 Pandemic: French Guidelines

scientific article published on 21 April 2020

Bénéfice et risques potentiels de l'association du trastuzumab à la chimiothérapie et à la radiothérapie dans le cancer du sein non métastatique

scientific article published on 20 July 2007

Cardiac prevention: the oncologic point of view

scientific article published in November 2004

Cardiovascular safety profiles of aromatase inhibitors : a comparative review.

scientific article published on January 2006

Castration-Dependent Pharmacokinetics of Docetaxel: Do Sex and/or ABCB1 Polymorphism Also Matter?

scientific article published on 11 April 2011

Chemotherapy in the elderly: how and for whom?

scientific article published in May 2008

Chemotherapy-induced cardiotoxicity in the elderly

scientific article published on 01 May 2008

Clues to differentiate pregnancy-associated breast cancer from those diagnosed in postpartum period: A monocentric experience of pregnancy-associated cancer network (CALG)

scientific article published on 3 May 2017

Comparison of two nomograms to predict pathologic complete responses to neoadjuvant chemotherapy for breast cancer: evidence that HER2-positive tumors need specific predictors

scientific article published on 9 December 2011

Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric study

scientific article published on 15 March 2008

Concurrent trastuzumab--internal mammary irradiation for HER2 positive breast cancer: "It hurts to be on the cutting edge".

scientific article published on 4 May 2009

Discordance With Local Guidelines for Adjuvant Chemotherapy in Breast Cancer: Reasons and Effect on Survival

scientific article published on 01 March 2011

Docetaxel in the treatment of breast cancer: current experience and future prospects.

scientific article

Does Concurrent Radiochemotherapy Affect Cosmetic Results in the Adjuvant Setting After Breast-Conserving Surgery? Results of the ARCOSEIN Multicenter, Phase III Study: Patients’ and Doctors’ Views

scientific article published on 01 May 2007

Délais au traitement du cancer du sein : expérience d’un centre expert (CEX) de l’Assistance Publique des Hôpitaux de Paris (AP–HP)

scientific article published on 30 June 2014

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).

scientific article

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†

scientific article

Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast cancer patients.

scientific article

Endometriosis and non-Hodgkin's lymphoma

scientific article published on 01 November 1997

Evaluation of the costs and resource use associated with adjuvant chemotherapy for breast cancer in France.

scientific article published on August 2012

Evaluation of the quantitative analytical methods real-time PCR for HER-2 gene quantification and ELISA of serum HER-2 protein and comparison with fluorescence in situ hybridization and immunohistochemistry for determining HER-2 status in breast can

scientific article published on July 2005

Fight against cancer around the Mediterranean area: “Many hands make light work!”

article

First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity

scientific article

Genetic abnormalities in synovial sarcoma.

scientific article published in June 1998

High dose chemotherapy in ovarian and breast adenocarcinoma with poor prognosis

scientific article published in September 2000

High p95HER2/HER2 Ratio Associated With Poor Outcome in Trastuzumab-Treated HER2-Positive Metastatic Breast Cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance).

scientific article

High-dose therapy and hematopoietic cell autotransplantation in the treatment of adult gynecologic tumors

scientific article published in April 1996

How to combine hormonotherapy and radiation treatment in adjuvant breast cancer?

scientific article

Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability

scientific article

Impact of immunohistochemical analysis of sentinel lymph node biopsy on breast cancer management.

scientific article published in August 2012

Influence of ABCB1 polymorphisms and docetaxel pharmacokinetics on pathological response to neoadjuvant chemotherapy in breast cancer patients

scientific article published on 11 May 2013

Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer

scientific article

Les décisions des RCP sont-elles conformes au référentiel utilisé ? Expérience d’un centre de référence universitaire pour le cancer du sein

scientific article published on 06 March 2013

Long-term follow-up of HER2-overexpressing stage II or III breast cancer treated by anthracycline-free neoadjuvant chemotherapy.

scientific article published on 6 August 2010

Looking for predictive markers in breast cancer – Authors' reply

scientific article published on 29 December 2014

Maintenance capecitabine and bevacizumab versus bevacizumab alone after initial first-line bevacizumab and docetaxel for patients with HER2-negative metastatic breast cancer (IMELDA): a randomised, open-label, phase 3 trial.

scientific article published on 28 September 2014

Malignant cardiac tumors

scientific article

Mechanisms of action of bisphosphonates on tumor cells and prospects for use in the treatment of malignant osteolysis.

scientific article

Mediterranean collaboration in the fight against cancer: "it is as if the past had never existed"

scientific article

Multicenter Phase II Trial of Neoadjuvant Therapy With Trastuzumab, Docetaxel, and Carboplatin for Human Epidermal Growth Factor Receptor-2–Overexpressing Stage II or III Breast Cancer: Results of the GETN(A)-1 Trial

scientific article published on 21 May 2007

Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact

scientific article published on 14 May 2014

Myotax: A phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines

scientific article published in November 2011

Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study

scientific article published on 28 February 2012

Novel therapeutic strategies combining antihormonal and biological targeted therapies in breast cancer: focus on clinical trials and perspectives.

scientific article published on 16 August 2007

Optimal sequence of implied modalities in the adjuvant setting of breast cancer treatment: an update on issues to consider

scientific article published on November 2010

Optimal treatment strategies in postmenopausal women with hormone-receptor-positive and HER2-negative metastatic breast cancer

scientific article

Ostéonécrose mandibulaire et bisphosphonates : état actuel et perspectives

scientific article published on 20 March 2009

Pathological response and circulating tumor cell count identifies treated HER2+ inflammatory breast cancer patients with excellent prognosis: BEVERLY-2 survival data

scientific article published on 23 December 2014

Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study

scientific article published on 28 July 2014

Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas: the ITOV 01 protocol

scientific article published in April 2006

Physiopathology and management of osteonecrosis of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysis.

scientific article published on 12 December 2008

Preclinical pharmacology of the taxanes: implications of the differences.

scientific article published on January 2004

Predicting the likelihood of recurrence of pregnancy-associated breast cancer: Nomogram based on analysis of the French cancer network: Cancer Associé à La Grossesse

scientific article published on 20 April 2020

Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study

scientific article published on 19 August 2013

Pregnancy-associated breast cancer is as chemosensitive as non-pregnancy-associated breast cancer in the neoadjuvant setting

scientific article

Pregnancy-associated breast cancers: do they differ from other breast cancers in young women?

scientific article published on 13 June 2012

Prevalence and Treatment Management of Oropharyngeal Candidiasis in Cancer Patients: Results of the French Candidoscope Study

article

Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management

scientific article published on 01 September 2007

Prognosis of HER2-positive pregnancy-associated breast cancer: Analysis from the French CALG (Cancer Associé à La Grossesse) network

scientific article published on 26 November 2020

Prognostic role of pregnancy occurring before or after treatment of early breast cancer patients aged <35 years: a GET(N)A Working Group analysis.

scientific article published in November 2009

Propensity score to evaluate prognosis in pregnancy-associated breast cancer: Analysis from a French cancer network

scientific article published on 14 April 2018

Pulmonary Artery Obstruction and Giant Cell Arteritis

scientific article published on 01 May 1995

Radiotherapy and combined therapy in breast cancer: standards and innovations in the adjuvant setting

scientific article published on 5 November 2010

Radiotherapy for invasive breast cancer: guidelines for clinical practice from the French expert review board of Nice/Saint-Paul de Vence

scientific article published on 07 July 2010

Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Resu

scientific article published on 19 January 2005

Synovial sarcoma. Epidemiologic and histologic data, prognostic factors and treatment

scientific article published on December 6, 1997

Taxane therapy for early stage breast cancer

scientific article published in January 2006

The Global Need for a Trastuzumab Biosimilar for Patients With HER2-Positive Breast Cancer

scientific article published on 2 February 2018

The use of GnRH analogues in early and advanced breast carcinomas

scientific article

Treatment of hot flashes in women with a previous diagnosis of breast cancer

scientific article published in April 2004

Triple negative breast cancer: proposals for a pragmatic definition and implications for patient management and trial design

scientific article published on 08 October 2011

Updates on gemcitabine at the American Society of Clinical Oncology congress (ASCO, 2002)

scientific article

Use of aromatase inhibitors and bisphosphonates as an anticancer therapy in postmenopausal breast cancer.

scientific article published on 30 September 2010

Use of guidelines and heterogeneity of decision making for adjuvant chemotherapy in hormone-receptor positive, HER2-negative, early breast cancer: results of a French national survey

scientific article published in October 2014

Which breast cancer decisions remain non-compliant with guidelines despite the use of computerised decision support?

scientific article published on 13 August 2013

[Adenocarcinoma of the pancreas. Diagnosis and evaluation]

scientific article published on 01 March 1998

[Adenocarcinoma of the pancreas. General characteristics]

scientific article published on 01 March 1998

[Anticancer chemotherapy in the elderly: a review of the literature]

scientific article published on 01 May 2008

[Anticancer drugs off label used of: what do the experts think about?]

scientific article published on 01 October 2004

[Anticancer drugs use evaluation: limits of the approved labeling]

scientific article published on 01 May 2004

[Bevacizumab and taxanes in the first-line treatment of metastatic breast cancer : overall survival and subgroup analyses of the ATHENA study in France].

scientific article published in September 2014

[Cost-effectiveness of a chemotherapy predictive test].

scientific article

[Dose density and dose intensity in the treatment of breast cancer]

scientific article published on 01 December 2004

[Expert centre Cancer du sein et Grossesse (CALG): Concordance between the proposed therapeutics and those finally received]

scientific article published on 15 December 2018

[From San Antonio to Saint-Gallen: reflections of Saint-Paul-de-Venice or how to treat breast cancer]

scientific article published on 01 March 2003

[HER-2/neu positive breast cancer: how to prescribe adjuvant trastuzumab (Herceptin)?]

article

[High-dose chemotherapy in ovarian adenocarcinoma]

scientific article published on 01 January 2000

[Impact of taxanes in the adjuvant setting of node-negative breast cancers]

scientific article published on 01 May 2013

[Node negative breast cancer. Beyond international consensus: a pragmatic approach]

scientific article published on 01 July 2011

[Oocyte/embryo cryopreservation before chemotherapy for breast cancer]

scientific article published on 10 August 2011

[Pregnancy after cancer: for whom and when?]

scientific article published on 24 April 2015

[Renal insufficiency and breast cancer]

scientific article published on 01 March 2012

[Somatostatin in breast cancer]

scientific article published on 01 July 2011

[The use of breast cancer subtype classification to predict local and distant recurrence. A review]

article

[Treatments of metastases in cancer]

scientific article published on 01 March 2012

[Updates on gemcitabine on metastatic breast cancer]

scientific article published on 01 January 2007

Paulina is supported by:

About Paulina

Help